Woodline Partners LP - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 105 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$20,060,000
-35.1%
1,000,000
-8.7%
0.24%
-35.8%
Q2 2023$30,889,217
-17.1%
1,094,974
-49.4%
0.37%
-27.8%
Q1 2023$37,247,477
+1162.2%
2,165,551
+1378.0%
0.51%
+1200.0%
Q4 2022$2,950,893
-57.4%
146,519
-54.2%
0.04%
-59.8%
Q3 2022$6,926,000
+36.0%
319,747
+76.4%
0.10%
+24.4%
Q2 2022$5,094,000
+171.0%
181,272
+344.9%
0.08%
+151.6%
Q1 2022$1,880,000
-93.9%
40,748
-88.9%
0.03%
-93.0%
Q4 2021$30,949,000
-8.6%
368,173
-27.5%
0.44%
-19.9%
Q3 2021$33,843,000
+25.8%
507,847
+0.4%
0.55%
+10.2%
Q2 2021$26,902,000
+330.1%
505,675
+250.8%
0.50%
+261.2%
Q1 2021$6,255,000
-14.0%
144,161
+3.0%
0.14%
-28.0%
Q4 2020$7,272,000
+61.3%
140,000
+1.5%
0.19%
+30.4%
Q3 2020$4,507,000
+114.6%
137,884
+215.3%
0.15%
+78.3%
Q2 2020$2,100,00043,7260.08%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Paradigm Biocapital Advisors LP 300,434$25,254,0007.21%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,628,409$220,944,0006.56%
Avidity Partners Management LP 2,715,000$228,223,0004.84%
Matrix Capital Management Company, LP 4,349,279$365,600,0004.07%
Affinity Asset Advisors, LLC 117,500$9,877,0003.59%
Integral Health Asset Management, LLC 120,000$10,087,0002.79%
Ghost Tree Capital, LLC 80,000$6,725,0002.41%
Ikarian Capital, LLC 191,140$16,067,0002.39%
Tri Locum Partners LP 23,632$1,987,0000.78%
Eventide Asset Management 529,000$44,468,0000.57%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders